Allopurinol enhances the activity of hypoxanthine-guanine phosphoribosyltransferase in inflammatory bowel disease patients during low-dose thiopurine therapy: preliminary data of an ongoing series.
about
How I treat my inflammatory bowel disease-patients with thiopurines?6-methylmercaptopurine-induced leukocytopenia during thiopurine therapy in inflammatory bowel disease patients.Use of thiopurines in inflammatory bowel disease: Safety issues.Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity.Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use.What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails?The role of thiopurine metabolite monitoring in inflammatory bowel disease.Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD.Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease.Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal.Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
P2860
Q28076561-3AC26D08-DB48-40AF-837F-DB8A8640A4B1Q33436894-E345FEF5-04BC-4C01-ACC7-31EAB72AB8A4Q33621267-FB8B4A04-B9E8-47F9-A476-876F050906FDQ34805821-CD6CD627-69FE-4EE1-AF69-C663B0C30426Q38179509-6D3B8FFF-B9B9-4F52-96BB-D7328DFFB0F4Q38191583-41844D4E-6373-4EE4-B626-927B75962C25Q38200692-54C6CB25-6023-440B-B33C-52611BDEEB1DQ38253469-0F7C8D72-29AB-4D01-9355-F0AD243DA6B9Q38417177-E80D5927-6949-420F-A902-F47F81AAA6ABQ42756142-303D2263-08B4-4337-AB60-9C8B03A8DD8AQ44316625-47A2FF15-F1AA-4599-A698-E359347B4F12
P2860
Allopurinol enhances the activity of hypoxanthine-guanine phosphoribosyltransferase in inflammatory bowel disease patients during low-dose thiopurine therapy: preliminary data of an ongoing series.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Allopurinol enhances the activ ...... ary data of an ongoing series.
@ast
Allopurinol enhances the activ ...... ary data of an ongoing series.
@en
Allopurinol enhances the activ ...... ary data of an ongoing series.
@nl
type
label
Allopurinol enhances the activ ...... ary data of an ongoing series.
@ast
Allopurinol enhances the activ ...... ary data of an ongoing series.
@en
Allopurinol enhances the activ ...... ary data of an ongoing series.
@nl
prefLabel
Allopurinol enhances the activ ...... ary data of an ongoing series.
@ast
Allopurinol enhances the activ ...... ary data of an ongoing series.
@en
Allopurinol enhances the activ ...... ary data of an ongoing series.
@nl
P2093
P2860
P1476
Allopurinol enhances the activ ...... ary data of an ongoing series.
@en
P2093
Adriaan A van Bodegraven
Dirk P van Asseldonk
Gerd Bouma
Godefridus J Peters
Margien L Seinen
Nanne K H de Boer
P2860
P304
P356
10.1080/15257770.2011.597371
P577
2011-12-01T00:00:00Z